Published in Clin Exp Immunol on August 01, 1979
Anti-acetylcholine receptor antibodies. J Neurol Neurosurg Psychiatry (1980) 1.20
A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES. J Histochem Cytochem (1964) 10.70
Autoimmune response to acetylcholine receptor. Science (1973) 4.59
Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Science (1974) 2.69
An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin Immunol Immunopathol (1977) 2.10
Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction. Lancet (1975) 1.84
Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis. Lancet (1975) 1.66
Antibodies to salivary duct cells, and other autoantibodies, in patients with Sjögren's syndrome and other idiopathic autoimmune diseases. Clin Exp Immunol (1968) 1.60
Acetylcholine receptor antibodies in myasthenia gravis. N Engl J Med (1975) 1.52
A radioimmunoassay for the quantitative evaluation of anti-human acetylcholine receptor antibodies in myasthenia gravis. Clin Exp Immunol (1977) 1.23
The skeletal muscle binding site of antistriated muscle antibody in myasthenia gravis: an electron microscopic immunohistochemical study using peroxidase conjugated antibody fragments. J Immunol (1973) 1.07
Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann N Y Acad Sci (1975) 5.23
Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum (1997) 3.29
Conjugation of fluorescein isothiocyanate to antibodies. II. A reproducible method. Immunology (1970) 3.09
Conjugation of fluorescein isothiocyanate to antibodies. I. Experiments on the conditions of conjugation. Immunology (1970) 2.56
Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum (1979) 2.23
Antibodies to gluten and reticulin in gastrointestinal diseases. Clin Exp Immunol (1978) 1.83
The antiperinuclear factor. 1. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis. Ann Rheum Dis (1979) 1.81
Long-term followup of patients with Sjögren's syndrome. Arthritis Rheum (1996) 1.76
Immunology of DNA. I. The influence of reaction conditions on the Farr assay as used for the detection of anti-ds DNA. J Immunol Methods (1976) 1.63
A periodic acid-silver methenamine restaining method for cryostat sections of renal tissue previously used in the immunofluorescence technique. J Histochem Cytochem (1969) 1.61
Antibodies to salivary duct cells, and other autoantibodies, in patients with Sjögren's syndrome and other idiopathic autoimmune diseases. Clin Exp Immunol (1968) 1.60
Myasthenia gravis, autoantibodies, and HL-A antigens. Br Med J (1974) 1.47
Circulating antibodies to corneal tissue in a patient suffering from Mooren's ulcer (ulcus rodens corneae). Clin Exp Immunol (1969) 1.44
Measles antibodies in sera from patients with autoimmune diseases. Lancet (1972) 1.39
Formalinized chicken red cell nuclei as a simple antigen for standardized antinuclear factor determination. Clin Exp Immunol (1969) 1.37
Autospermagglutinins: immunofluorescent studies. Ann N Y Acad Sci (1965) 1.36
Detection of antibodies to DNA by radioimmunoassay and immunofluorescence. Scand J Rheumatol Suppl (1975) 1.30
Cryoglobulins in New Zealand Black mice. Clin Exp Immunol (1969) 1.28
Studies on sera from cases of myasthenia gravis, using the fluorescent antibody technique. Vox Sang (1967) 1.28
Detection of anti-dsDNA as diagnostic tool. Ann Rheum Dis (1981) 1.21
Immunology of DNA. II. The effect of size and structure of the antigen on the Farr assay. J Immunol Methods (1976) 1.20
Long-term course of tear gland function in patients with keratoconjunctivitis sicca and Sjögren's syndrome. Br J Ophthalmol (1997) 1.13
The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27. Invest Ophthalmol Vis Sci (1991) 1.09
Studies on drug induced lupus erythematosus in mice. I. Drug induced antinuclear antibodies (ANA). Clin Exp Immunol (1972) 1.08
Joint report of 1st International Workshop on Canine Immunogenetics. Tissue Antigens (1973) 1.06
Wheat grains: a substrate for the determination of gluten antibodies in serum of gluten-sensitive patients. J Immunol Methods (1977) 1.06
Elution of antibodies from biopsy tissue. J Clin Pathol (1970) 1.06
Human fibroblasts, a convenient nuclear substrate for detection of anti-nuclear antibodies including anti-centromere antibodies. Scand J Rheumatol (1983) 1.01
HL-A antigens, autoantibody production, and associated diseases in thymoma patients, with and without myasthenia gravis. Ann N Y Acad Sci (1976) 1.01
Entrance and survival of Salmonella typhimurium and Yersinia enterocolitica within human B- and T-cell lines. Infect Immun (1994) 0.99
Antibodies against the various types of skeletal muscle fibres. Immunology (1965) 0.99
Monoclonal immunoglobulins demonstrable in cerebrospinal fluid by use of cellulose acetate electrophoresis. Clin Chem (1980) 0.96
Muscle antibodies in myasthenic mothers and their babies. Lancet (1966) 0.96
Possible ankylosing spondylitis in acute anterior uveitis. Br J Rheumatol (1983) 0.93
Analysis of T cell receptor-gene rearrangement in T cells from the cerebrospinal fluid of patients with multiple sclerosis. J Neuroimmunol (1987) 0.93
Penetration of the antinuclear factor (A.N.F.) into chicken red cells. Vox Sang (1967) 0.92
Muscle pathology, thymoma, and immunological abnormalities in patients with myasthenia gravis. J Neurol Neurosurg Psychiatry (1968) 0.92
The effect of 4-aminopyridine on clinical signs in multiple sclerosis: a randomized, placebo-controlled, double-blind, cross-over study. Ann Neurol (1992) 0.92
Incidence and significance of heartmuscle antibodies in patients with acute myocardial infarction and unstable angina. Acta Med Scand (1979) 0.92
An approach toward automation of antinuclear antibody (ANA) determination. Ann N Y Acad Sci (1971) 0.91
HLA-B27 subtypes positively and negatively associated with spondyloarthropathy. J Rheumatol (1997) 0.91
B27 positive diseases versus B27 negative diseases. Ann Rheum Dis (1988) 0.90
Acute anterior uveitis and HLA-B27 subtypes. Invest Ophthalmol Vis Sci (1988) 0.89
HLA-B27+ acute anterior uveitis and other antigens of the major histocompatibility complex. Invest Ophthalmol Vis Sci (1989) 0.89
The antiperinuclear factor: II. A light microscopical and immunofluorescence study on the antigenic substrate. Ann Rheum Dis (1980) 0.88
Anti-dsDNA and complement profiles in systemic lupus erythematosus. Neth J Med (1981) 0.88
Antibodies to Klebsiella pneumoniae in Dutch patients with ankylosing spondylitis and acute anterior uveitis and to Proteus mirabilis in rheumatoid arthritis. J Rheumatol (1998) 0.88
A familial study of the inheritance of HLA-B27-positive acute anterior uveitis. Am J Ophthalmol (1988) 0.88
Evaluation of the visual system in multiple sclerosis: a comparative study of diagnostic tests. Clin Neurol Neurosurg (1992) 0.87
Preparation of antisera directed against the idiotype(s) of immunoglobulin G from the cerebrospinal fluid of patients with multiple sclerosis. J Immunol (1980) 0.87
Hypothyroidism after thyroidectomy for Graves's disease: a search for an explanation. Br Med J (1974) 0.87
Epidermal antibodies in secondary syphilis. Br J Vener Dis (1978) 0.86
Expression of HLA class I heavy chains and beta 2-microglobulin does not affect human cytomegalovirus infectivity. J Gen Virol (1991) 0.86
Immunofluorescence microphotometry for the detection of platelet antibodies. I. Standardization of the method. Scand J Immunol (1973) 0.84
LDH-IgA immunoglobulin complexes in human serum. Clin Chim Acta (1975) 0.84
Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis. Neurology (1980) 0.84
Comparison of peptides eluted from the groove of HLA-B27 from Salmonella infected and non-infected cells. Clin Rheumatol (1996) 0.83
[Autoimmunity in myasthenia and thymoma]. Ann Inst Pasteur (Paris) (1970) 0.83
Spondylarthropathy and selective IgA deficiency. Rheumatol Int (1995) 0.82
Seronegative spondyloarthropathies and HLA-B27 subtyes: a study in Asian Indians. Clin Rheumatol (1996) 0.82
Autoantibodies related to treatment with chlorthalidone and alpha-methyldopa. Acta Med Scand (1970) 0.82
Psychiatric symptoms before systemic lupus erythematosus is diagnosed. Rheumatol Int (1994) 0.81
Studies on the standardization of antinuclear antibody (ANA) determination. Ann N Y Acad Sci (1971) 0.80
The use of HLA-B27 as a diagnostic and prognostic aid in acute anterior uveitis (AAU) in The Netherlands. Doc Ophthalmol (1986) 0.80
Is actin in eye lens a possible factor in visual accomodation? Nature (1980) 0.80
The preparation of astatine labelled proteins. Int J Appl Radiat Isot (1975) 0.80
Analysis of cerebrospinal fluid and serum of patients with multiple sclerosis by means of anti-idiotypic antisera. J Immunol (1982) 0.80
Acute anterior uveitis (AAU) and HLA-B27. Br J Rheumatol (1983) 0.80
Antibodies to D.N.A. and viruses. Lancet (1971) 0.79
New views on B27 associated diseases. Neth J Med (1989) 0.79
HLA-antigens in the human uvea. Doc Ophthalmol (1986) 0.79
Association of Gm allotypes with the occurrence of ankylosing spondylitis in HLA-B27-positive anterior uveitis. Am J Ophthalmol (1986) 0.79
The cerebrospinal fluid immunoglobulin G index as a diagnostic aid in multiple sclerosis: a Bayesian approach. Clin Chem (1982) 0.78
Immunology of AS in AAU patients. Immunol Today (1994) 0.78
IgA antibodies in HLA-B27 associated acute anterior uveitis and ankylosing spondylitis. Clin Rheumatol (1996) 0.77
Segregation of HLA haplotypes in 100 families with a myasthenia gravis patient. J Immunogenet (1977) 0.77
Antibodies to a 15 kD nuclear antigen in patients with juvenile chronic arthritis and uveitis. Invest Ophthalmol Vis Sci (1992) 0.77
Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis. Clin Exp Immunol (1982) 0.77
Evidence that HLA-B*2706 is not protective against spondyloarthropathy. J Rheumatol (1999) 0.77
IgA antibodies against Klebsiella and other Gram-negative bacteria in ankylosing spondylitis and acute anterior uveitis. Clin Rheumatol (1996) 0.76
Influence of infection of cells with bacteria associated with reactive arthritis on the peptide repertoire presented by HLA-B27. J Med Microbiol (2001) 0.76
HLA-B27 as a receptor for cytomegalovirus. Curr Eye Res (1992) 0.76
Lymphoid proliferations in the orbit: malignant or benign? Br J Ophthalmol (1984) 0.75
[Clinical findings and diagnosis of Yersinia enterocolitica infections; a retrospective study in Friesland]. Ned Tijdschr Geneeskd (1992) 0.75
Lactate dehydrogenase (LDH)-IgG3 immunoglobulin complexes in human serum. Clin Chim Acta (1975) 0.75
Perivascular infiltration in normal skin of patients with rheumatoid arthritis: association with rheumatoid factors and HLA-DR antigens. Ann Rheum Dis (1988) 0.75
4-Aminopyridine in multiple sclerosis. Ann Neurol (1990) 0.75
Failure to detect long-acting thyroid stimulator with the immunofluorescence technique. Clin Exp Immunol (1970) 0.75
[Autoimmunity and aging]. Ned Tijdschr Geneeskd (1977) 0.75
[Immunological aspects of rheumatoid arthritis]. Ned Tijdschr Geneeskd (1980) 0.75
[HL-A and disease]. Ned Tijdschr Geneeskd (1977) 0.75
Antinuclear antibodies. Scand J Rheumatol Suppl (1975) 0.75
[Systemic lupus erythematosus (SLE). II. New insights into its etiology]. Ned Tijdschr Geneeskd (1974) 0.75
[HL-A typing and autoantibodies in patients with myasthenia gravis]. Ned Tijdschr Geneeskd (1974) 0.75
Clinical management of SLE patients. Neth J Med (1978) 0.75
[Systemic lupus erythematosus (SLE). I. New insights into serology and pathogenesis]. Ned Tijdschr Geneeskd (1974) 0.75
A chronic clotting defect with some characteristics of excessive intravascular coagulation in a patient with Gaucher's disease. Folia Med Neerl (1967) 0.75
Heterogeneity of rearranged T cell receptor V alpha and V beta gene transcripts in synovial fluid T cells of HLA-B27 positive reactive arthritis patients. Clin Rheumatol (1996) 0.75